Capital Change Notice
Capital Change Notice
Updated as at 17 October 2019
25 August 2021
Notice of issue of Ordinary Shares
This notice is given under NZX Listing Rule 3.13.1 and 3.15.2 and relates to the automatic
exercise of time-based rights.
Section 1: Issuer information
Name of issuer The a2 Milk Company Limited
NZX ticker code ATM
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZATME0002S8
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 94,219 Ordinary Shares
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security Not applicable
Nature of the payment (for example, cash or
other consideration)
Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1
0.013% of the total number of Ordinary
Shares on issue at the date of this notice
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial
Product) or the Option (for example, the
exercise price and exercise date)
Not applicable
Reason for issue/acquisition/redemption and
specific authority for
issue/acquisition/redemption/ (the reason for
change must be identified here)
Ordinary Shares issued to employees as a
result of the automatic exercise of time-
based, as authorised by a Board Resolution
dated 27 July 2021.
The time-based rights were granted to
employees as part of the on-going long term
incentive arrangements that the entity has
adopted to assist in the reward, retention and
motivation of its employees and relevant
contractors.
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
Total number of Financial Products of the Class
after the
issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number
of Financial Products of the Class held as
Treasury Stock after the
issue/acquisition/redemption.
743,604,875 Ordinary Shares.
There is no Treasury Stock.
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
Not applicable
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Board Resolution dated 27 July 2021 and
NZX Listing Rule 4.9.1(b).
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
All Ordinary Shares issued rank equally with
the existing Ordinary Shares
Date of issue/acquisition/redemption
2
25 August 2021
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this
announcement
Jaron McVicar, Chief Legal and Sustainability
Officer & Company Secretary
Contact person for this announcement Jaron McVicar
Contact phone number +61 2 9697 7000
Contact email address Jaron.McVicar@a2milk.com
Date of release through MAP
25 August 2021
Listing Rule 3.15.2 – Time-based Rights
The following details are provided for the purposes of NZX Listing Rule 3.15.2:
(a) Number of Financial Products
converted and the number and class of
Quoted Financial Products into which
they have been converted:
94,219 time-based rights converted into
94,219 Ordinary Shares
(b) Interest or dividend conditions
attaching to the Financial Products into
which they have been converted:
None
(c) Number of Financial Products of the
same class remaining to be converted:
447,582 time-based rights
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: Capital Change Notice – Issue of ordinary shares2021-07-14
“Capital Change Notice AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 14 July 2021 Issue of ordinary shares This notice is given un…”
- AFT — AFT Pharmaceuticals Limited: Capital Change Notice – Issue of ordinary shares2021-09-05
“Capital Change Notice AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 6 September 2021 Issue of ordinary shares This notice is give…”
- AFT — AFT Pharmaceuticals Limited: Capital Change Notice – Issue of ordinary shares2021-06-20
“Capital Change Notice AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 21 June 2021 Issue of ordinary shares This notice is given un…”